Skip to main content
. 2022 Nov 16;24(4):e202200537. doi: 10.1002/cbic.202200537

Table 3.

Synthetic methods used in chemical protein synthesis, indicating use in reported D‐protein synthesis and potential issues encountered with use.

Entry

Used in D‐protein synthesis

#

Synthetic method

Reagents

Y / N

Potential issues

Ref.

Ligation method

graphic file with name CBIC-24-e202200537-g033.jpg

1

Native chemical ligation

+ thiol catalyst

Y

Dependence on suitable cysteine or alanine residues.

[97a]

graphic file with name CBIC-24-e202200537-g024.jpg

2

Serine/threonine ligation

+ acidolysis

N

Requires suitable Ser/Thr. Slower reaction kinetics than NCL.

[145]

3

KAHA ligation

graphic file with name CBIC-24-e202200537-g028.jpg

N

Accessibility of enantiomeric reagent.

[146]

graphic file with name CBIC-24-e202200537-g002.jpg

4

Selenocysteine NCL

+ thiol catalyst

N

Accessibility of enantiomeric reagent.

[123a]

NCL reactive end

Thioester surrogate

graphic file with name CBIC-24-e202200537-g012.jpg

5

Hydrazides

Activation+NaNO2 + Thiol

Y

Oxidation incompatible with Thz. Low temperature activation needed (<−15 °C).

[100]

graphic file with name CBIC-24-e202200537-g021.jpg

6

Dbz

Activation 4‐nitrophenyl chloroformate or NaNO2 or isoamyl nitrite +thiol

Y

Di‐acylation side product with excess Gly.

[16, 147]

graphic file with name CBIC-24-e202200537-g015.jpg

7

MeDbz

Activation 4‐nitrophenyl chloroformate +thiol

N

Difficult to activate off‐resin.

[98]

graphic file with name CBIC-24-e202200537-g030.jpg

8

SEA

Activation of SEA OFF TCEP+thiol

N

Latent SEAOFF thioester incompatible with TCEP during ligations.

[148]

N‐cysteine protection

graphic file with name CBIC-24-e202200537-g001.jpg

9

Thz

Deprotection MeONH2

Y

Incompatible with hydrazide oxidation.

[103]

graphic file with name CBIC-24-e202200537-g013.jpg

10

Cys(Tfacm)

Deprotection pH 11.5

N

Accessibility of enantiomeric reagent.

[149]

graphic file with name CBIC-24-e202200537-g003.jpg

11

TFA‐Thz

Deprotection Base then MeONH2

Y

Accessibility of enantiomeric reagent.

[41]

graphic file with name CBIC-24-e202200537-g014.jpg

12

N3‐Cys

Deprotection TCEP

N

Accessibility of enantiomeric reagent.

[150]

graphic file with name CBIC-24-e202200537-g020.jpg

13

Cys(Dobz)

Deprotection H2O2

N

Accessibility of enantiomeric reagent. Harsh deprotection conditions.

[151]

Desulfurization

14

Metal‐based

Pd/Al2O3 Or Raney Nickel+ H2 (g)

Y

Removal of metal impurities can be problematic. Use of hydrogen gas. Potential side reactions with Trp and Met Quenched by thiol catalyst. Native Cys must be protected.

[108]

15

Metal‐free radical based

VA‐044 TCEP tert‐butylthiol

Y

Quenched by thiol catalyst. Native Cys must be protected.

[106]

16

Beta/gamma thiol amino acids

β‐thiol‐Phe β‐thiol‐Val β‐thiol‐Leu β‐thiol‐Asp β‐thiol‐Asn β‐thiol‐Arg γ‐thiol‐Val γ‐thiol‐Thr γ‐thiol‐Ile γ‐thiol‐Pro γ‐thiol‐Glu γ‐thiol‐Gln γ‐thiol‐Lys 2‐thiol‐Trp

N

Accessibility of enantiomeric reagent. Commercially available D‐Penicillamine (β‐thiol‐Val) could be used for D‐peptide ligation at Val, if directly following a glycine residue.

[152]

Thiol catalysts for one‐pot ligation‐desulfurization

graphic file with name CBIC-24-e202200537-g034.jpg

17

MPAA‐hydrazide

pKa=6.6 Removal Aldehyde‐resin capture

N

Preparation of MPAA‐hydrazide reagent coupled with use in large excess is uneconomical.

[153]

graphic file with name CBIC-24-e202200537-g039.jpg

18

Trifluoroethanthiol

pKa=7.3 Removal Evaporation (bp=37 °C)

N

Malodorous and volatile, though could be used for D‐protein synthesis.

[154]

graphic file with name CBIC-24-e202200537-g027.jpg

19

Methyl thioglycolate

pKa=7.9 Removal none

Y

Slower kinetics with C‐terminal beta‐branched residue.

[41]

Solubility enhancers

graphic file with name CBIC-24-e202200537-g023.jpg

20

Helping hand v1

Installation Amine labelling with lysine side chain Removal Hydrazine (aq)

N

Additional steps to incorporate and remove tag. Potential issues with stability.

[119a]

graphic file with name CBIC-24-e202200537-g004.jpg

21

Helping hand v2

Installation Amine labelling with lysine side chain Removal Hydrazine (aq) Or Hydroxylamine (aq)

N

Additional steps to incorporate and remove tag.

[119b]

graphic file with name CBIC-24-e202200537-g011.jpg

22

Removable backbone modification v1

Installation Standard Fmoc‐SPPS Removal pH 7 then TFA

Y

Limited to Gly only. Lengthy synthesis of building block. Additional steps to incorporate and remove tag.

[117, 155]

graphic file with name CBIC-24-e202200537-g029.jpg

23

Removable backbone modification v2

Installation Reductive amination Acetylation Removal Deacetylation (Cys (aq)) then TFA

Y

Additional steps to incorporate and remove tag.

[77b, 118]

Protein folding

graphic file with name CBIC-24-e202200537-g022.jpg

Disulfide #1 Removal TFA

graphic file with name CBIC-24-e202200537-g032.jpg

Disulfide #2 Removal Iodine or PdCl2

graphic file with name CBIC-24-e202200537-g040.jpg

24

Cysteine orthogonal protection

Disulfide #3 Removal UV light (350 nm)

Y

Practically limited to two disulfide bonds. Accessibility of a third, orthogonally protected D‐Cys building block.

[52, 128]

25

“Ambidextrous” chaperone

GroEL/ES protein chaperone

Y

Mostly unnecessary for in‐vitro protein folding. Limited scope reported.

[121b]

Post‐translational modifications

26

Lys ubiquitination

δ‐mercapto lysine for NCL followed by desulfurization

N

Accessibility of enantiomeric reagent.

[136a]

27

Solid‐phase isopeptide bond formation

N

Requires assembly of large fragments by SPPS – not cost‐effective with D‐amino acids

[156]

graphic file with name CBIC-24-e202200537-g016.jpg

28

Installation Coupling to lysine side chain PTM NCL to Ub‐thioester Auxiliary removal TFA

N

Low efficiency of ligation. Glycyl auxiliary replaced with Cys in preparation of enantiomeric di‐ and tri‐ubiquitin proteins.

[28, 42]

29

Lys trimethylation

Fmoc‐Lys(Me3)‐OH

N

Accessibility of enantiomeric reagent.

[133a, 151]

30

Lys acetylation

Fmoc‐Lys(Ac)‐OH

N

Accessibility of enantiomeric reagent.

[133b]

31

Asn N‐Glycosylation

Fmoc‐Asn(Glycan)−OH or Boc‐Asn(Xan)−OH (and) further glycosylation on‐resin or in solution.

N

Accessibility of enantiomeric reagent (would also require L‐sugars).

[53, 157]

32

Oligosaccharide coupled directly to free Asn side chain during Boc‐SPPS.

N

Accessibility of enantiomeric reagent (would also require L‐sugars).

[158]

33

Thr O‐Glycosylation

Fmoc‐Thr(Glycan)−OH

N

Accessibility of enantiomeric reagent (would also require L‐sugars).

[131b]

34

Cys S‐palmitoylation

Fmoc‐Cys(Mmt)−OH Mmt removal on‐resin with 2 % TFA Reaction with palmitic anhydride

N

Incompatible with NCL. Potentially viable for D‐protein synthesis via STL or Sec NCL.

[137a]

35

Fmoc‐Cys(palmityl)‐OH

N

Incompatible with NCL. Fmoc‐D‐Cys(palmityl) must be synthesized.

[137b]

36

Tyr sulfation

Fmoc‐Tyr(OTBS)−OH Deprotection and sulfation on‐resin with:

N

Accessibility of enantiomeric reagent.

[131b]

graphic file with name CBIC-24-e202200537-g019.jpg

+DIEPA

37

Ser phosphorylation

graphic file with name CBIC-24-e202200537-g010.jpg

Y

Accessibility of enantiomeric reagent.

[18, 130b, 159]

38

Tyrosine phosphorylation

graphic file with name CBIC-24-e202200537-g005.jpg

N

Accessibility of enantiomeric reagent.

[131a]